The recent good news on vaccine development means that countries in Emerging Asia are likely to start inoculating their populations sooner than we had previously envisaged. In response, we are raising some of our GDP growth forecasts for next year and 2022.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services